Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the third quarter ended September 30, 2025, and provide an update on recent developments, on November 4, 2025.
Compass management will host a conference call at 8:00 am ET (1:00 pm UK) on November 4, 2025. A live webcast of the call will be available on the Compass Pathways website at: https://events.q4inc.com/attendee/698442687. The webcast will be archived for 30 days.
About Compass Pathways
Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational COMP360 synthesized psilocybin treatment, potentially a first in class treatment. COMP360 has Breakthrough Therapy designation from the US Food and Drug Administration (FDA) and has received Innovative Licensing and Access Pathway (ILAP) designation in the UK for treatment-resistant depression (TRD).
Compass is headquartered in London, UK, with offices in New York in the US. We envision a world where mental health means not just the absence of illness but the ability to thrive.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251028541021/en/
Contacts
Enquiries
Media: Dana Sultan-Rothman, media@compasspathways.com, +1 484 432 0041
Investors: Stephen Schultz, stephen.schultz@compasspathways.com, +1 401 290 7324
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
70 Percent of Consumers Don’t Care What Brands Are Saying Anymore28.10.2025 14:30:00 EET | Press release
CSG® (NASDAQ: CSGS) today released its 2026 State of the Customer Experience Report, which finds consumers in an era of total digital saturation, bombarded with brand communications in every channel, all day, every day. The research indicates that in 2026, clarity will be the most crucial driver of customer trust and loyalty. CSG’s global survey of 1,200 digital citizens found that consumers are struggling to identify which brand messages are important—and which interactions they can trust. Seven out of ten consumers feel brands send so many messages, they don’t care what brands are saying anymore. 59% of consumers have deleted critical messages, like bills or fraud alerts, mistaking them for marketing or spam. Almost two-thirds of consumers worry they’ll miss critical messages because of the overwhelming number of communications that brands send today. Consumers are divided on whether they trust agentic AI: 56% are uncomfortable letting AI take action on their behalf. More than one-th
Esri Signs Strategic Collaboration Agreement with AWS to Advance Generative AI in ArcGIS28.10.2025 14:00:00 EET | Press release
Esri, the global leader in geographic information system (GIS) and geospatial AI technology, has signed a strategic collaboration agreement (SCA) with Amazon Web Services (AWS) to advance the integration of Generative AI (GenAI) into geospatial solutions and workflows. Bringing Esri’s geospatial AI platform, ArcGIS, together with the scalable cloud infrastructure on AWS enables organizations to deploy enterprise-scale geospatial AI solutions with greater efficiency and reliability, while leveraging the advanced cloud capabilities on AWS alongside ArcGIS software’s sophisticated mapping and spatial analysis tools. “AWS’s cloud capabilities combined with Esri’s geospatial expertise empower customers to solve complex challenges through advanced location intelligence,” said Amy Belcher, AWS director, WWPS global ISV sales and GTM. “This strategic agreement will accelerate the development of Generative AI-powered solutions that deliver meaningful business outcomes while simplifying how orga
FoodChain ID and IDFL Announce Strategic Worldwide Partnership to Advance Regenerative Agriculture and Certifications in the Textile Industry28.10.2025 14:00:00 EET | Press release
FoodChain ID and IDFL today announced a strategic worldwide partnership that unites leading expertise to strengthen transparency from farm to finished product in the textile industry. The collaboration combines FoodChain ID’s agricultural certifications with IDFL’s textile certifications and testing, offering brands a seamless pathway to verify regenerative agricultural practices alongside textile chain-of-custody, social accountability, chemical compliance, environmental performance and animal welfare. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251028455185/en/ The FoodChain ID and IDFL partnership allows brands to link on-farm regenerative outcomes with credible textile chain-of-custody and quality claims. “By aligning FoodChain ID’s Regenerative Agriculture Certification with IDFL’s textile certification and testing capabilities, we’re making it easier for companies to implement credible sustainability programs across
BeOne Medicines to Present at Upcoming Investor Conferences28.10.2025 12:01:00 EET | Press release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in fireside chats at two upcoming investor conferences: Guggenheim Second Annual Healthcare Innovation Conference on Monday, November 10, 2025 at 9:30 am EST; and Jefferies Global Healthcare Conference in London on Monday, November 17, 2025 at 4:00 pm GMT/11:00 am EST Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through
Allianz Reports Safety Gains From Automated Mobility and Urges EU-Wide “Driving License” for Autonomous Vehicles28.10.2025 11:05:00 EET | Press release
The promise of autonomous mobility is not just a technological leap – it represents a transformation in safety, comfort, and accessibility that is already underway with Level 3 vehicles on European roads and Level 4 systems operating in real-world test fields. At the 13th Allianz Motor Day in 2025, hosted by the Allianz Center for Technology (AZT), Allianz unveiled significant safety gains from autonomous vehicles and calls for EU-wide testing standards to ensure their safe integration into European roads, including questions about vehicle safety, liability, the use of in-vehicle data from autonomous vehicles (AVs), and more inclusive mobility. The company already insures test fields in several countries, including Germany, Norway, and Singapore. AZT research and proprietary claims analysis indicate a significant decline in motor liability claims frequency driven by advanced driver assistance systems (ADAS) now available in select models. While these systems already demonstrate impress
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom